Home
About Us
Services
Patents
Patent Searching
Patent Drafting
Patent Filing
Patent Prosecution
Patent Opposition
Trademarks
Copyrights
Designs
Blog & News
Career
Contact Us
New Drug Approved_May 2016
Home
IPaatEntiti
New Drug Approved_May 2016
June 7, 2016
|
ipaatentiti
|
IPaatEntiti
New Drug Approved_May 2016
Original New Drug Application (NDA and BLA) New molecular entity_ Approvals-May 2016
Active Ingredient(s); Drug name
Company
Approval Date
FLUCICLOVINE; AXUMIN (NDA)
BLUE EARTH DIAGNOSTICS LTD
27/05/2016
DACLIZUMAB; ZINBRYTA (BLA)
BIOGEN
27/05/2016
About the Author
ipaatentiti
Post navigation
New Indian IPR Policy_India
Subject Matter Eligibility of Software related Patents
Recent Posts
GREAT NEWS FOR ALL INDIAN EDUCATIONAL INSTITUTES TO BOOST THEIR INNOVATION
Decathlon Sues Pentathlon for Trademark Infringement
Government Proposal to Shut Down IPAB
DRAFT PATENTS (AMENDMENT) RULES, 2021
New Beginnings
Delhi HC ruled in favour of “MakeMyTrip”- Temporary ad-interim injunction continues
DPIIT Launches Website and Mobile App for IPR
The Patents (Amendment) Rules, 2019
New IPR Policy for Academic Institutions on the anvil
Government of India initiative to boost Intellectual Property Rights
Burden of Proof in case of Process Patent
Hindustan Zinc receives its first European patent
Patent infringement actions are maintainable only in respect of granted and live patents
Patentability of Microorganisms in India
Expedited Examination Procedure in Indian Patent System